Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard D Moore

Showing results (51-60 of 500) with videos related to

Pageof 50
Sort By:
Epidemiology (Cambridge, Mass.)|May 30, 2009
Evaluation of human immunodeficiency virus biomarkers: inferences from interval and clinical cohort studiesBryan Lau, Stephen J Gange, Gregory D Kirk, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 27, 2010
Immunologic and virologic predictors of AIDS-related non-hodgkin lymphoma in the highly active antiretroviral therapy eraEric A Engels, Ruth M Pfeiffer, Ola Landgren, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 14, 2012
Trends in reasons for hospitalization in a multisite United States cohort of persons living with HIV, 2001-2008Stephen A Berry, John A Fleishman, Richard D Moore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 26, 2005
Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatmentJoel E Gallant, Michelle A Parish, Jeanne C Keruly, et al.
AIDS (London, England)|February 28, 2008
Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individualsJessica L Long, Eric A Engels, Richard D Moore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2008
Rate of comorbidities not related to HIV infection or AIDS among HIV-infected patients, by CD4 cell count and HAART use statusRichard D Moore, Kelly A Gebo, Gregory M Lucas, et al.
AIDS (London, England)|April 20, 2002
Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinicGregory M Lucas, Kelly A Gebo, Richard E Chaisson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 21, 2005
An improvement in virologic response to highly active antiretroviral therapy in clinical practice from 1996 through 2002Richard D Moore, Jeanne C Keruly, Kelly A Gebo, et al.
Medical Care|November 11, 2010
The economic burden of late entry into medical care for patients with HIV infectionJohn A Fleishman, Baligh R Yehia, Richard D Moore, et al.
Medical Care|August 24, 2005
High rates of primary Mycobacterium avium complex and Pneumocystis jiroveci prophylaxis in the United StatesKelly A Gebo, John A Fleishman, Erin D Reilly, et al.
Pageof 50

Showing results (51-60 of 500) with videos related to

Sort By:
Pageof 50
Epidemiology (Cambridge, Mass.)|May 30, 2009
Evaluation of human immunodeficiency virus biomarkers: inferences from interval and clinical cohort studiesBryan Lau, Stephen J Gange, Gregory D Kirk, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 27, 2010
Immunologic and virologic predictors of AIDS-related non-hodgkin lymphoma in the highly active antiretroviral therapy eraEric A Engels, Ruth M Pfeiffer, Ola Landgren, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 14, 2012
Trends in reasons for hospitalization in a multisite United States cohort of persons living with HIV, 2001-2008Stephen A Berry, John A Fleishman, Richard D Moore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 26, 2005
Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatmentJoel E Gallant, Michelle A Parish, Jeanne C Keruly, et al.
AIDS (London, England)|February 28, 2008
Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individualsJessica L Long, Eric A Engels, Richard D Moore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2008
Rate of comorbidities not related to HIV infection or AIDS among HIV-infected patients, by CD4 cell count and HAART use statusRichard D Moore, Kelly A Gebo, Gregory M Lucas, et al.
AIDS (London, England)|April 20, 2002
Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinicGregory M Lucas, Kelly A Gebo, Richard E Chaisson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 21, 2005
An improvement in virologic response to highly active antiretroviral therapy in clinical practice from 1996 through 2002Richard D Moore, Jeanne C Keruly, Kelly A Gebo, et al.
Medical Care|November 11, 2010
The economic burden of late entry into medical care for patients with HIV infectionJohn A Fleishman, Baligh R Yehia, Richard D Moore, et al.
Medical Care|August 24, 2005
High rates of primary Mycobacterium avium complex and Pneumocystis jiroveci prophylaxis in the United StatesKelly A Gebo, John A Fleishman, Erin D Reilly, et al.
Pageof 50